Evidence map›Paper›PMID 41955302›Full record

ArticleHuman molecular genetics2026

Genetic variation near ROBO1 is associated with craniofacial microsomia and related phenotypes in the Finnish population.

Laura Kaprio, Anu Kiukkonen, Emma Juuri, David P Rice, Hanna M Ollila, Satu Strausz

Abstract read
In one paragraph

Article in Human molecular genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura KaprioCleft Palate and Craniofacial Centre, Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, Park Hospital, Stenbäckinkatu 11, 00029 HUS, Helsinki, Finland.ORCID 0009-0009-0827-2821
Anu KiukkonenDepartment of Oral and Maxillofacial Diseases, Head and Neck Center University of Helsinki and Helsinki University Hospital, Park Hospital, Stänbackinkatu 11, 00029 HUS, Helsinki, Finland.
Emma JuuriCleft Palate and Craniofacial Centre, Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, Park Hospital, Stenbäckinkatu 11, 00029 HUS, Helsinki, Finland.
David P RiceOrthodontics, Department of Oral and Maxillofacial Disease, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 1A, 00290, Helsinki, Finland.ORCID 0000-0001-9301-3078
Hanna M OllilaInstitute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Tukholmankatu 8, 00290, Helsinki, Finland.
Satu StrauszCleft Palate and Craniofacial Centre, Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, Park Hospital, Stenbäckinkatu 11, 00029 HUS, Helsinki, Finland.

Funding

AbbVie Inc.AstraZeneca UK LtdBiogen MA Inc.Boehringer Ingelheim International GmbHBristol Myers SquibbBusiness Finland HUS 4685/31/2016Business Finland UH 4386/31/2016Finnish Dental Society ApolloniaFinnish Medical FoundationFinnish Sleep Research Society (S.S.)Genentech Inc.GlaxoSmithKline Intellectual Property Development LtdInstrumentarium Science FoundationInstrumentarium Science Foundation and Academy of Finland #340539 (H.M.O.)Janssen Biotech IncMaze Therapeutics Inc.Merck Sharp & Dohme LCCNovartis AGPfizer Inc.Sanofi US Services Inc.
6 · The paper itself

Abstract

Craniofacial microsomia (CFM) encompasses a phenotypic continuum of congenital anomalies ranging from isolated microtia to more complex manifestations within the oculo-auriculo-vertebral spectrum, including Goldenhar syndrome, reflecting abnormal development of first and second pharyngeal arch-derived structures. While several genetic susceptibility loci have been reported, population-based evidence in individuals of European ancestry remains limited. Using nationwide data from FinnGen in the Finnish founder population, we identified a genome-wide significant association at a conserved intergenic locus near ROBO1, extending previous findings to a European ancestry cohort. The lead variant, rs62256696, lies within a regulatory region active in human embryonic craniofacial tissues during early development and shows concordant association with previously reported ROBO1 signals from non-European populations. Genetic correlation analyses demonstrated strong shared genetic architecture between CFM and auditory developmental phenotypes, consistent with the defined phenotypic continuum. Together, these findings extend previous observations to a new population context and support a role for regulatory variation at the ROBO1 locus in early craniofacial morphogenesis and auditory system development underlying craniofacial and auditory malformations.

Indexed as

Goldenhar SyndromeNerve Tissue ProteinsReceptors, ImmunologicEuropean PeopleFemaleFinlandGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansMalePhenotypePolymorphism, Single NucleotideRoundabout ProteinsWhite PeopleNerve Tissue ProteinsReceptors, ImmunologicRoundabout ProteinsCraniofacial microsomiaGWASMicrotiaROBO1

Identifiers

PMID41955302
PMCPMC13064855

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.